Wed, May 11, 2022
Tue, May 10, 2022
Mon, May 9, 2022
Fri, May 6, 2022

Gena Wang Maintained (BLUE) at Sell with Decreased Target to $3 on, May 10th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-3-on-may-10th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Gena Wang of Barclays, Maintained "bluebird bio, Inc." (BLUE) at Sell with Decreased Target from $4 to $3 on, May 10th, 2022.

Gena has made no other calls on BLUE in the last 4 months.



There are 4 other peers that have a rating on BLUE. Out of the 4 peers that are also analyzing BLUE, 3 agree with Gena's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $8 on, Wednesday, April 6th, 2022
  • Yaron Werber of "Cowen & Co." Downgraded from Buy to Hold on, Wednesday, April 6th, 2022
  • Yanan Zhu of "Wells Fargo" Maintained at Hold with Decreased Target to $8 on, Tuesday, March 8th, 2022


This is the rating of the analyst that currently disagrees with Gena


  • Matthew Harrison of "Morgan Stanley" Maintained at Sell with Decreased Target to $5 on, Monday, March 7th, 2022

Publication Contributing Sources